Back Article

Ababneh MJ, Al-Kasasbeh A, Jarrah M, Malkawi L, Sanduka O, Smadi AM, Smadi MM. 2022. Myocardial injury and its correlation to mortality in hospitalized covid-19 patients: A retrospective cohort study. Front Cardiovasc Med, 9: 1039655.

Ammirati E, Wang DW. 2020. Sars-cov-2 inflames the heart. The importance of awareness of myocardial injury in covid-19 patients. Int J Cardiol, 311: 122-123.

Artico J, Shiwani H, Moon JC, Gorecka M, McCann GP, Roditi G, Morrow A, Mangion K, Lukaschuk E, Shanmuganathan M, Miller CA, Chiribiri A, Prasad SK, Adam RD, Singh T, Bucciarelli-Ducci C, Dawson D, Knight D, Fontana M, Manisty C, Treibel TA, Levelt E, Arnold R, Macfarlane PW, Young R, McConnachie A, Neubauer S, Piechnik SK, Davies RH, Ferreira VM, Dweck MR, Berry C, Greenwood JP. 2023. Myocardial involvement after hospitalization for covid-19 complicated by troponin elevation: A prospective, multicenter, observational study. Circulation, 147: 364-374.

Bonow RO, Fonarow GC, O'Gara PT, Yancy CW. 2020. Association of coronavirus disease 2019 (covid-19) with myocardial injury and mortality. JAMA Cardiol, 5: 751-753.

Cao Z, Gao W, Bao H, Feng H, Mei S, Chen P, Gao Y, Cui Z, Zhang Q, Meng X, Gui H, Wang W, Jiang Y, Song Z, Shi Y, Sun J, Zhang Y, Xie Q, Xu Y, Ning G, Gao Y, Zhao R. 2023. Vv116 versus nirmatrelvir-ritonavir for oral treatment of covid-19. N Engl J Med, 388: 406-417.

Case BC, Shea C, Rappaport H, Cellamare M, Zhang C, Zhu M, Medranda GA, Satler LF, Ben-Dor I, Hashim H, Rogers T, Waksman R. 2023. The evolving impact of myocardial injury in patients with covid-19 amid the omicron wave of the pandemic. Am J Cardiol, 190: 54-60.

Castiello T, Georgiopoulos G, Finocchiaro G, Claudia M, Gianatti A, Delialis D, Aimo A, Prasad S. 2022. Covid-19 and myocarditis: A systematic review and overview of current challenges. Heart Fail Rev, 27: 251-261.

Chen C, Li H, Hang W, Wang DW. 2020. Cardiac injuries in coronavirus disease 2019 (covid-19). J Mol Cell Cardiol, 145: 25-29.

Chen F, Cheng Z, Peng Y, Wang Z, Huang C, Liu D, Wang B, Pan B, Guo W. 2021. A liquid chromatography-tandem mass spectrometry (lc-ms/ms)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin ii in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci, 1179: 122740.

Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV, 3rd, Kwon DH, Singh T, Tilton JC, Tsai EJ, Tucker NR, Barnard J, Loscalzo J. 2021. Covid-19 and cardiovascular disease: From bench to bedside. Circ Res, 128: 1214-1236.

Del Rio C, Omer SB, Malani PN. 2022. Winter of omicron-the evolving covid-19 pandemic. Jama, 327: 319-320.

Faust JS, Du C, Liang C, Mayes KD, Renton B, Panthagani K, Krumholz HM. 2022. Excess mortality in massachusetts during the delta and omicron waves of covid-19. Jama, 328: 74-76.

Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, Kindermann I, Gutberlet M, Cooper LT, Liu P, Friedrich MG. 2018. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert recommendations. J Am Coll Cardiol, 72: 3158-3176.

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. 2020. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (covid-19). JAMA Cardiol, 5: 811-818.

Hanson PJ, Liu-Fei F, Ng C, Minato TA, Lai C, Hossain AR, Chan R, Grewal B, Singhera G, Rai H, Hirota J, Anderson DR, Radio SJ, McManus BM. 2022. Characterization of covid-19-associated cardiac injury: Evidence for a multifactorial disease in an autopsy cohort. Lab Invest, 102: 814-825.

Hartmann C, Miggiolaro A, Motta JDS, Baena Carstens L, Busatta Vaz De Paula C, Fagundes Grobe S, Hermann de Souza Nunes L, Lenci Marques G, Libby P, Zytynski Moura L, de Noronha L, Pellegrino Baena C. 2021. The pathogenesis of covid-19 myocardial injury: An immunohistochemical study of postmortem biopsies. Front Immunol, 12: 748417.

Henning RJ. 2022. Cardiovascular complications of covid-19 severe acute respiratory syndrome. Am J Cardiovasc Dis, 12: 170-191.

Iuliano AD, Brunkard JM, Boehmer TK, Peterson E, Adjei S, Binder AM, Cobb S, Graff P, Hidalgo P, Panaggio MJ, Rainey JJ, Rao P, Soetebier K, Wacaster S, Ai C, Gupta V, Molinari NM, Ritchey MD. 2022. Trends in disease severity and health care utilization during the early omicron variant period compared with previous sars-cov-2 high transmission periods - united states, december 2020-january 2022. MMWR Morb Mortal Wkly Rep, 71: 146-152.

Jansson S, Blixt PJ, Didriksson H, Jonsson C, Andersson H, Hedström C, Engvall J, Aneq M, Chew MS. 2022. Incidence of acute myocardial injury and its association with left and right ventricular systolic dysfunction in critically ill covid-19 patients. Ann Intensive Care, 12: 56.

Koc HC, Xiao J, Liu W, Li Y, Chen G. 2022. Long covid and its management. Int J Biol Sci, 18: 4768-4780.

Kotecha T, Knight DS, Razvi Y, Kumar K, Vimalesvaran K, Thornton G, Patel R, Chacko L, Brown JT, Coyle C, Leith D, Shetye A, Ariff B, Bell R, Captur G, Coleman M, Goldring J, Gopalan D, Heightman M, Hillman T, Howard L, Jacobs M, Jeetley PS, Kanagaratnam P, Kon OM, Lamb LE, Manisty CH, Mathurdas P, Mayet J, Negus R, Patel N, Pierce I, Russell G, Wolff A, Xue H, Kellman P, Moon JC, Treibel TA, Cole GD, Fontana M. 2021. Patterns of myocardial injury in recovered troponin-positive covid-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J, 42: 1866-1878.

Kundura L, Gimenez S, Cezar R, André S, Younas M, Lin YL, Portalès P, Lozano C, Boulle C, Reynes J, Vincent T, Mettling C, Pasero P, Muller L, Lefrant JY, Roger C, Claret PG, Duvnjak S, Loubet P, Sotto A, Tran TA, Estaquier J, Corbeau P. 2022. Angiotensin ii induces reactive oxygen species, DNA damage, and t-cell apoptosis in severe covid-19. J Allergy Clin Immunol, 150: 594-603.e592.

Leng L, Ma J, Zhang PP, Xu SC, Li X, Jin Y, Cai J, Tang R, Zhao L, He ZC, Li MS, Zhang H, Zhou LR, Wu ZH, Li TR, Zhu YP, Wang YJ, Wu HB, Ping YF, Yao XH, Zhu CH, Guo HT, Tan LY, Liang ZY, Bian XW, Zhang SY. 2022. Spatial region-resolved proteome map reveals mechanism of covid-19-associated heart injury. Cell Rep, 39: 110955.

Li C, Wang DW, Zhao C. 2021. Cardiovascular involvement in patients with 2019 novel coronavirus disease. J Transl Int Med, 9: 152-160.

Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, Ammirati E, Wang DW. 2020. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized covid-19 patients. J Mol Cell Cardiol, 147: 74-87.

Li K, Shi J, Liu X, Ward MP, Wang Z, Liu R, Zhao Z, Yin Y, Liu Y, Hong J, Huang J, Chen X, Zhang Z. 2023. Early warning signals for omicron outbreaks in china: A retrospective study. J Med Virol, 95: e28341.

Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. 2022a. Covid-19 vaccine development: Milestones, lessons and prospects. Signal Transduct Target Ther, 7: 146.

Li Y, Pei H, Zhou C, Lou Y. 2022b. Myocardial injury predicts risk of short-term all-cause mortality in patients with covid-19: A dose-response meta-analysis. Front Cardiovasc Med, 9: 850447.

Lim GB. 2020. Myocardial injury in patients with covid-19. Nat Rev Cardiol, 17: 454.

Lin YF, Wu X, Li Y, Bian J, Li K, Jiang Y, Lu Z, Zhang B, Yang C, Sun C, Sun L, Zou H. 2023. Impact of combination preventative interventions on hospitalization and death under the pandemic of sars-cov-2 omicron variant in china. J Med Virol, 95: e28335.

Melillo F, Napolano A, Loffi M, Regazzoni V, Boccellino A, Danzi GB, Cappelletti AM, Rovere-Querini P, Landoni G, Ingallina G, Stella S, Ancona F, Dagna L, Scarpellini P, Ripa M, Castagna A, Tresoldi M, Zangrillo A, Ciceri F, Agricola E. 2022. Myocardial injury in patients with sars-cov-2 pneumonia: Pivotal role of inflammation in covid-19. Eur J Clin Invest, 52: e13703.

Metkus TS, Sokoll LJ, Barth AS, Czarny MJ, Hays AG, Lowenstein CJ, Michos ED, Nolley EP, Post WS, Resar JR, Thiemann DR, Trost JC, Hasan RK. 2021. Myocardial injury in severe covid-19 compared with non-covid-19 acute respiratory distress syndrome. Circulation, 143: 553-565.

Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. 2020. Covid-19 and cardiovascular disease: From basic mechanisms to clinical perspectives. Nat Rev Cardiol, 17: 543-558.

Siripanthong B, Asatryan B, Hanff TC, Chatha SR, Khanji MY, Ricci F, Muser D, Ferrari VA, Nazarian S, Santangeli P, Deo R, Cooper LT, Jr., Mohiddin SA, Chahal CAA. 2022. The pathogenesis and long-term consequences of covid-19 cardiac injury. JACC Basic Transl Sci, 7: 294-308.

Stuber M, Baggish AL. 2023. Acute myocardial injury in the covid-heart study: Emphasizing scars while reassuring scares. Circulation, 147: 375-377.

Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, Johnston TP, Sahebkar A. 2021. Covid-19 and cardiac injury: Clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther, 19: 345-357.

Telenti A, Arvin A, Corey L, Corti D, Diamond MS, García-Sastre A, Garry RF, Holmes EC, Pang PS, Virgin HW. 2021. After the pandemic: Perspectives on the future trajectory of covid-19. Nature, 596: 495-504.

Wadhera RK, Figueroa JF, Rodriguez F, Liu M, Tian W, Kazi DS, Song Y, Yeh RW, Joynt Maddox KE. 2021. Racial and ethnic disparities in heart and cerebrovascular disease deaths during the covid-19 pandemic in the united states. Circulation, 143: 2346-2354.

Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C. 2020a. Good or bad: Application of raas inhibitors in covid-19 patients with cardiovascular comorbidities. Pharmacol Ther, 215: 107628.

Wang K, Gheblawi M, Nikhanj A, Munan M, MacIntyre E, O'Neil C, Poglitsch M, Colombo D, Del Nonno F, Kassiri Z, Sligl W, Oudit GY. 2022. Dysregulation of ace (angiotensin-converting enzyme)-2 and renin-angiotensin peptides in sars-cov-2 mediated mortality and end-organ injuries. Hypertension, 79: 365-378.

Wang M, Liu Z, Wang Z, Li K, Tian Y, Lu W, Hong J, Peng X, Shi J, Zhang Z, Mei G. 2023. Clinical characteristics of 1139 mild cases of the sars-cov-2 omicron variant infected patients in shanghai. J Med Virol, 95: e28224.

Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B. 2020b. Comorbidities and multi-organ injuries in the treatment of covid-19. Lancet, 395: e52.

Wolfler A, Mannarino S, Giacomet V, Camporesi A, Zuccotti G. 2020. Acute myocardial injury: A novel clinical pattern in children with covid-19. Lancet Child Adolesc Health, 4: e26-e27.

Yeo YH, Wang M, He X, Lv F, Zhang Y, Zu J, Li M, Jiao Y, Ebinger JE, Patel JK, Cheng S, Ji F. 2023. Excess risk for acute myocardial infarction mortality during the covid-19 pandemic. J Med Virol, 95: e28187.

Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, Liu YM, Zhao YC, Huang X, Lin L, Xia M, Chen MM, Cheng X, Zhang X, Guo D, Peng Y, Ji YX, Chen J, She ZG, Wang Y, Xu Q, Tan R, Wang H, Lin J, Luo P, Fu S, Cai H, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu M, Chen M, Zhang XJ, Wang X, Touyz RM, Xia J, Zhang BH, Huang X, Yuan Y, Loomba R, Liu PP, Li H. 2020. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with covid-19. Circ Res, 126: 1671-1681.